Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Net Income (2025 - 2026)

Updated

Revium Rx (RVRC) posted Net Income of -$732,000 for Q2 2026.

Analysis

Revium Rx (RVRC) Net Income (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 210.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 3.62 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.51 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.50 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -248.00 Mn
10 Revium Rx 86.84 Mn 86.00 Mn - -748,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -748,000.00
Jun 30, 2025 -1.04 Mn
API Access

Revium Rx Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=RVRC&period=max&api_key=YOUR_API_KEY